Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Stargardt Disease

Oct 16, 2023

The Hidden World of Vision: Exploring the Top 5 Rare Eye Diseases

Jul 25, 2023

Gilead’s Magrolimab Plus Azacitidine for MDS; FDA Approveds VANFLYTA for Newly Diagnosed AML; FDA Awards Fast Track Designation to ARX517 mCRPC; EMA Rejects Mirati’s Krazati; Harmony Phase III Pitolisant Trial for PWS Patients; Belite Bio’s Phase 3 DRAGON Trial of Tinlarebant for STGD

Jan 16, 2018

Notizia

Jan 15, 2018

Retinal Degeneration : The Current Pipeline Scenario

Newsletter/Whitepaper